21 - 30 out of 58Page size: 10
  1. 2022

  2. Patients with hypothermic sepsis have a unique gene expression profile compared to patients with fever and sepsis

    Harmon, M. B. A., Scicluna, B. P., Wiewel, M. A., Schultz, M. J., Horn, J., Cremer, O. L., van der Poll, T., Joost Wiersinga, W., Juffermans, N. P., de Beer, F. M., Bos, L. D., Glas, G. J., Horn, J., Hoogendijk, A. J., van Hooijdonk, R. T., Huson, M. A., van der Poll, T., Scicluna, B., Schouten, L. R., Schultz, M. J., & 15 othersStraat, M., van Vught, L. A., Wieske, L., Wiewel, M. A., Witteveen, E., the MARS consortium, Bonten, M. J., Cremer, O. L., Frencken, J. F., van de Groep, K., Klein Klouwenberg, P. M., Koster–Brouwer, M. E., Ong, D. S., Varkila, M. R. & Verboom, D. M., Apr 2022, In: Journal of cellular and molecular medicine. 26, 7, p. 1896-1904 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?

    van Kempen, Z. L. E., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van Dam, P. J., Volkers, A. G., Boekel, L., Toorop, A. A., Strijbis, E. M. M., Tas, S. W., Wolbink, G. J., Löwenberg, M., van Sandt, C., ten Brinke, A., Verstegen, N. J. M., Steenhuis, M., Kuijpers, T. W., van Ham, S. M., Rispens, T., Eftimov, F., & 1 othersKillestein, J., 1 Jan 2022, In: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 57, 103416.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis

    van Lierop, Z. Y. GJ., Wieske, L., Koel-Simmelink, M. J. A., Chatterjee, M., Dekker, I., Leurs, C. E., Willemse, E. A. J., Moraal, B., Barkhof, F., Eftimov, F., Uitdehaag, B. M. J., Killestein, J. & Teunissen, C. E., Jan 2022, In: Multiple sclerosis (Houndmills, Basingstoke, England). 28, 1, p. 102-110 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study

    Peters-Sengers, H., Butler, J. M., Uhel, F., Schultz, M. J., Bonten, M. J., Cremer, O. L., Scicluna, B. P., van Vught, L. A., van der Poll, T., the MARS consortium, de Beer, F. M., Bos, L. D. J., Glas, G. J., van Hooijdonk, R. T. M., Horn, J., Schouten, L. R. A., Straat, M., Wieske, L., Witteveen, E., Reijnders, T. D. Y., & 12 othersSchuurman, A. R., van Engelen, T. S. R., Pereverzeva, L., Hoogendijk, A. J., Huson, M. A., Wiewel, M. A., Klouwenberg, P. M. C. K., Ong, D. S. Y., Frencken, J. F., Koster-Brouwer, M. E., van de Groep, K. & Verboom, D. M., Jan 2022, In: Intensive care medicine. 48, 1, p. 92-102 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273

    On behalf of the T2B immunity against SARS-CoV-2 study group, 2022, In: eLife. 11, e77969.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy

    van Veen, R., Pallada, G., Wieske, L., ten Holter, S. E. M., van Rootselaar, A. F., Verhamme, C., de Bie, R. M. A., van Schaik, I. N., Merkies, I. S. J., Dijk, J. M. & Eftimov, F., 2022, (E-pub ahead of print) In: Journal of the peripheral nervous system.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. 2021

  9. Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

    Boekel, L., Steenhuis, M., Hooijberg, F., Besten, Y. R., van Kempen, Z. L. E., Kummer, L. Y., van Dam, K. P. J., Stalman, E. W., Vogelzang, E. H., Cristianawati, O., Keijzer, S., Vidarsson, G., Voskuyl, A. E., Wieske, L., Eftimov, F., van Vollenhoven, R., Kuijpers, T. W., van Ham, S. M., Tas, S. W., Killestein, J., & 4 othersBoers, M., Nurmohamed, M. T., Rispens, T. & Wolbink, G., 1 Nov 2021, In: The Lancet Rheumatology. 3, 11, p. e778-e788

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy

    Bus, S. R. M., Wieske, L., Keddie, S., van Schaik, I. N. & Eftimov, F., 9 Oct 2021, In: Cochrane Database of Systematic Reviews. 2021, 10, CD014542.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Virus discovery in chronic inflammatory demyelinating polyneuropathy

    van Lieverloo, G. G. A., Wieske, L., van Schaik, I. N., Deijs, M., van der Hoek, L. & Eftimov, F., 15 Sep 2021, In: Journal of neuroimmunology. 358, 577668.

    Research output: Contribution to journal › Article › Academic › peer-review

  12. Adverse events after first COVID-19 vaccination in patients with autoimmune diseases

    Boekel, L., Kummer, L. Y., van Dam, K. P. J., Hooijberg, F., van Kempen, Z., Vogelzang, E. H., Wieske, L., Eftimov, F., van Vollenhoven, R., Kuijpers, T. W., van Ham, S. M., Tas, S. W., Killestein, J., Boers, M., Nurmohamed, M. T., Rispens, T. & Wolbink, G., 1 Aug 2021, In: The Lancet Rheumatology. 3, 8, p. e542-e545

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

Previous 1 2 3 4 5 6 Next

ID: 5182908